NYSEARCA:RGNT

Regentis Biomaterials Stock Forecast

etoro logo Buy RGNT
*Your capital is at risk
$1.85
-0.0400 (-2.12%)
At Close: Aug 10, 2026

Should you buy RGNT stock?

Last updated:

Based on market data through , StockInvest.us rates Regentis Biomaterials Ltd. (RGNT) as a Sell Candidate with a technical score of -4.47 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 27.17%
  • 3-month trend forecast Up 0.20%
  • Sell Candidate -4.47
AI Analysis AI Analysis of RGNT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RGNT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Regentis Biomaterials Ltd. stock price ended at $1.85 on Monday, after losing 2.12%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 14, 2026 Loss -27.17%

The Regentis Biomaterials Ltd. stock price fell by -2.12% on the last day (Monday, 10th Aug 2026) from $1.89 to $1.85. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.83% from a day low at $1.80 to a day high of $1.91. The price has fallen in 5 of the last 10 days and is down by -10.19% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -25 thousand shares and in total, 17 thousand shares were bought and sold for approximately $31.91 thousand.

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $1.29 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Regentis Biomaterials Ltd. stock with a 90% probability to be traded between $1.30 and $9.43 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

RGNT Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Regentis Biomaterials Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.92 and $2.83. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 15, 2026, and so far it has fallen -80.32%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Regentis Biomaterials Ltd. stock

Regentis Biomaterials Ltd. finds support from accumulated volume at $1.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.105 between high and low, or 5.83%. For the last week the stock has had daily average volatility of 9.99%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RGNT) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Regentis Biomaterials Ltd. to open at $1.85, and during the day (based on 14 day Average True Range), to move between $1.66 and $2.04, which gives a possible trading interval of +/-$0.388 (+/-23.42%) up or down from last closing price. If Regentis Biomaterials Ltd. takes out the full calculated possible swing range there will be an estimated 23.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.90 (2.70%) than the support at $1.78 (3.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Regentis Biomaterials Ltd. stock A Buy?

Regentis Biomaterials Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.472 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $1.85 ( 0.0901%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RGNT Performance

Trading levels for RGNT

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.96 5.77%
R2 1.92 3.60%
R1 1.89 2.26%
Price 1.85
S1 1.81 -2.08%
S2 1.79 -3.42%
S3 1.75 -5.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.28 23.24%
R2 1.96 5.95%
R1 1.90 2.70%
Price 1.85
S1 1.78 -3.78%
S2 1.76 -4.86%
S3 1.50 -18.92%

FAQ

What is the symbol for Regentis Biomaterials Ltd. Stock and on which exchange is it traded?
The symbol for Regentis Biomaterials Ltd. is RGNT and it is traded on the NYSEARCA (NYSE Arca).

Should I buy or sell Regentis Biomaterials Ltd. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Regentis Biomaterials Ltd. (RGNT) as a Sell Candidate with a technical score of -4.47 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Jul 14, 2026, the price has fallen 27.17%. The current 3-month trend forecast projects a rise of 0.20%.

How to buy Regentis Biomaterials Ltd. Stock?
Regentis Biomaterials Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Regentis Biomaterials Ltd. Stock.

What's the current price of Regentis Biomaterials Ltd. Stock?
As of the end of day on the Aug 10, 2026, the price of an Regentis Biomaterials Ltd. (RGNT) share was $1.85.

What is the 52-week high and low for Regentis Biomaterials Ltd. Stock?
The 52-week high for Regentis Biomaterials Ltd. Stock is $15.50 and the 52-week low is $1.23.

What is the market capitalization of Regentis Biomaterials Ltd. Stock?
As of the Aug 10, 2026, the market capitalization of Regentis Biomaterials Ltd. is 7.284M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE